| PERIOD ENDING | 27-Dec-08 | 27-Sep-08 | 28-Jun-08 | 29-Mar-08 | | Total Revenue | 9,599,000 | 9,445,000 | 9,236,000 | 8,710,000 | | Cost of Revenue |
-
|
-
|
-
| (8,419,000) | | | Gross Profit | 9,599,000 | 9,445,000 | 9,236,000 | 17,129,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 8,382,000 | 7,993,000 | 7,215,000 | 15,231,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
| 91,000 |
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,217,000 | 1,361,000 | 2,021,000 | 1,898,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 261,000 | 188,000 | 32,000 |
-
| | Earnings Before Interest And Taxes | 1,478,000 | 1,688,000 | 2,228,000 | 2,042,000 | | Interest Expense | 139,000 | 301,000 | 141,000 | 147,000 | | Income Before Tax | 1,339,000 | 1,387,000 | 2,087,000 | 1,895,000 | | Income Tax Expense | 488,000 | 490,000 | 712,000 | 712,000 | | Minority Interest | (6,000) | (137,000) | (91,000) | (50,000) | | | | Net Income From Continuing Ops | 845,000 | 760,000 | 1,284,000 | 1,133,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 845,000 | 760,000 | 1,284,000 | 1,133,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $845,000 | $760,000 | $1,284,000 | $1,133,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
